Lyra Direct SARS-CoV-2 Assay
The Lyra Direct SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the in vitro qualitative detection of human coronavirus SARS-CoV-2 from viral RNA extracted from nasal, nasopharyngeal (NP) or oropharyngeal (OP) swab specimens from patients with signs and symptoms of COVID-19. The Assay targets the non-structural Polyprotein (pp1ab) of the SARS-CoV-2 virus.
Availability: Commercially Available
9975 Summers Ridge Road
San Diego, CA 92121
North America
|
|
www.quidel.com
| Manufacturer |
| Quidel Corporation |
| Product Name |
| Lyra Direct SARS-CoV-2 Assay |
| Detection Category |
| Biological |
| Detection Principle |
| Molecular; |
| Detection Method |
| Assays; |
| Application |
| Diagnostics; |
| Equipment Type |
| Diagnostic |
| Product Synopsis |
| The Lyra Direct SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the in vitro qualitative detection of human coronavirus SARS-CoV-2 from viral RNA extracted from nasal, nasopharyngeal (NP) or oropharyngeal (OP) swab specimens from patients with signs and symptoms of COVID-19. The Assay targets the non-structural Polyprotein (pp1ab) of the SARS-CoV-2 virus. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| User Feedback Sources |
| Indifferent/No user feedback |
| No Information Is Available |
| Transportability |
| Pocket Size |
| Operating Conditions |
| Store the unopened kit at 2°C to 8°C;
Run Assay procedures at controlled room temperature of 20°C to 25°C. |
| Calibration Schedule |
| Not applicable |
| Suggested Routine Maintenance |
| Not applicable |
| Sample Introduction |
| Liquid; |
| Total Run Time |
| < 2 hours |
| Software Control |
| Not applicable |
| Other Operational Parameters |
| Assay available for use on Applied Biosystems® 7500 Fast Dx, Applied Biosystems 7500 Standard, Roche LightCycler® 480 Instrument II, Roche cobas® z 480, Qiagen Rotor-Gene® Q, Bio-Rad CFX96 Touch™, Thermo Fisher QuantStudio™ 7 Pro. |
| Training Required |
| <1 day training |
